Pharmaceutical Filtration Market Size, Hospital Procurement Trends, Manufacturing Capacity, Sales Performance, Regulatory Approvals, Competitive Landscape, and Forecast

Revenue, 2025

USD 13.64 Bn

Forecast Year, 2035

USD 21.23 Bn

CAGR, 2026 - 2035

4.52%

Report Coverage

Global

What is the Pharmaceutical Filtration Market Size?

The global pharmaceutical filtration market size is accounted at USD 13.64 billion in 2025 and predicted to increase from USD 14.27 billion in 2026 to approximately USD 21.23 billion by 2035, growing at a CAGR of 4.52% from 2026 to 2035. Filtration can be easily applied to a large variety of pharmaceutical needs due to its flexibility, which helps the growth of the market. The pharmaceutical filtration market is driven by growing biopharmaceutical production and stringent quality regulations.

Pharmaceutical Filtration Market Key Takeaways

• North America dominated the pharmaceutical filtration market in 2025.
• By product, the membrane filters segment has the largest market share in 2025.
• By product, the single-use systems segment is the fastest-growing segment over the forecast period.
• By application, the final product processing segment dominated the pharmaceutical filtration market in 2025.
• By application, the cell separation segment is projected to hit significant growth from 2026 to 2035.
• By technique, the microfiltration segment captured the biggest revenue share in the pharmaceutical filtration market in 2025.
• By technique, the ultrafiltration segment is expected to witness significant growth over the forecast period.
• By the scale of operation, the manufacturing scale registered a maximum market share in 2025.
• By the scale of operation, the research and development scale segment is predicted to hit notable growth over the forecast period.
• By systems, the single-use segment accounted for a considerable revenue share in the market in 2025.
• By systems, the reusable segment is expected to grow with the highest CAGR in the market during the studied years.
• By type, the sterile filtration segment held a dominant position in the market with a share in 2025.
• By type, the non-sterile filtration segment is expected to grow at the fastest CAGR in the market between 2026 and 2035.

Strategic Overview of the Global Pharmaceutical Filtration Industry

The pharmaceutical filtration market refers to the production, distribution, and use of this filtration which is a mechanical or physical operation used to separate solids from fluids (liquids or gases) by interposing a medium through which the fluid can pass. It is a process in which a solid particulate matter is removed from a fluid, which can be either liquid or gas, using a gas or porous medium. The purpose of filtration in the pharmaceutical industry is to remove impurities in the product and ensure that the API or finished product meets the specified quality standards. There is a high demand for this filtration in air purification, water purification, cell separation, and media buffer, which will help the growth of the market.

Artificial Intelligence: The Next Growth Catalyst in Pharmaceutical Filtration

Artificial Intelligence (AI) offers pharmaceutical formulation development has streamlined has streamlined this process for a more precise, cost-effective, and efficient approach. By using experimental data, AI algorithms can identify correlations among drug formulations, operating parameters, and quality attributes of pharmaceutical products. AI is advantageous in water purification and wastewater treatment processes due to automation facilities. AI helps researchers cut water usage, and sewer management, maintain a stable water supply, avoid water loss, and identify anomalies that help the growth of the pharmaceutical filtration market.

Pharmaceutical Filtration Market Growth Factors

• This filtration helps to remove impurities in the product and ensure that API or finished product.
• It helps to separate solids, from solids or liquids, ensuring that the medications produced are free and pure from contaminants.
• These filtrations are essential for maintaining the safety and effectiveness of pharmaceutical products.
• Filtration technology will play an important role in reducing production costs, improving product purity, and enhancing overall efficiency.

Market Outlook

• Market Growth Overview: The Pharmaceutical Filtration market is expected to grow significantly between 2026 and 2035, driven by the rising focus on biologics, biosimilars, and vaccines, the adoption of single-use technology, and innovation in nanofiber membranes technology.
• Sustainability Trends: Sustainability trends focus on water conservation and wastewater management, integration of automation, IoT sensors, and AI/machine learning enables real-time monitoring and predictive maintenance of filtration systems.
• Major Investors: Major investors in the market include Danaher Corporation (Pall Corporation, Cytiva), Merck KGaA (MilliporeSigma), and Sartorius AG.
• Startup Economy: The startup economy in the market is focused on innovation in niche areas like advanced membranes and specialized solutions for cell and gene therapies. Many startups leverage single-use technologies and digitalization to enhance efficiency and agility in bioprocessing, allowing them to compete with larger players.

Pharmaceutical Filtration Market Trends and Statistics

• In February 2025, US-based Thermo Fisher Scientific Inc. announced its purchase of Solventum's purification and filtration unit for $4.1 billion. That deal was among the latest deals related to pharmaceuticals and their filtration infrastructure.
• The new venture brought in about $1 billion in revenue in 2024, underscoring why filtration technologies that are used for biologics, sterile injectables, and vaccine manufacturing have become a commercial must.
• Working globally through the Americas, Europe, Asia-Pacific, and the Middle East with a workforce of 2,500 is part of an emerging trend towards more globally connected production responding to the escalating requirements for pharmaceutical filtration solutions.
• Also, this acquisition reflects an attitude change for the perception of filtration systems that they are no longer just add-ons for the processing process, but key components of the economics, as well as process efficiency of production of biopharmaceuticals.

Future Outlook and Strategic Recommendations

• Long-term Industry Outlook: Pharmaceutical filtration will steadily grow as biologics production expands and sterile manufacturing of pharmaceuticals gets under ever-res Stringent Regulatory Scrutineering. Market growth will continue to accelerate as a result of the increasing usage of single-use technologies and advanced membrane filtration.
• Emerging Business Models: The spread of filtration-as-a-service, digital monitoring, and integrated bioprocessing is enabling manufacturers to enhance the efficiency of their operations. Other strategic collaborations between the filtration technology vendors and biopharmaceutical firms are generating new business opportunities.
• Strategic Recommendations for Stakeholders: Advanced filtration, single-use systems, and AI to optimize processes should be investments for stakeholders to be competitive. Growth in manufacturing capacity and working with CDMOs will create opportunities in the new markets.

Market Scope

Market Dynamics

Driver

Increasing demand for generic medications

The pharmaceutical filtration process is essential for many stages of drug development including drug formulation, manufacturing, and packaging. This separation process is used to remove unwanted particles, bacteria, and other contaminants from solids, gases, or liquids in drug production. These filtration techniques provide the pharmaceutical industry with effective and reliable means of purifying and separating substances. These also help to maintain product integrity and meet regulatory requirements requiring the production of high-quality pharmaceutical products which help the growth of the pharmaceutical filtration market.

Restraint

High operational costs and technological limitations:

High operational costs and technological limitations can hamper the growth of the pharmaceutical filtration market. The initial investment in the membrane technology and ongoing maintenance can be expensive mainly for smaller companies. Rising competition among manufacturers creates pricing pressures, forcing companies to innovate continuously at the time of cost management. While technological advancements have been made, some existing filtration technologies may not meet the evolving demands for sensitivity, scalability, and purity in drug production.

Opportunity

Adoption of advanced technologies and sustainability initiatives:

Adoption of advanced technologies and sustainability initiatives will help the growth of the pharmaceutical filtration market. The advancement in membrane materials like ultrafiltration and nanofiltration can improve performance, leading to better separation efficiency and lower fouling rates. The integration of real-time monitoring systems and automated systems with the membrane filtration process can reduce human error and improve operational efficiency, driving productivity. The development of sustainable manufacturing processes will help to improve environmentally friendly filtration solutions.

Segment Insights

Product Insights

The membrane filter segment has the largest pharmaceutical filtration market share in 2025. A membrane filter is a type of filter made from synthetic materials like Teflon, nylon, or cellulose acetate designed with fine interconnected channels. Membrane filtration is one of the methods of sterilization when heat sterilization cannot be performed. It is suitable for removing contaminating microorganisms, bacteria, particulates, and natural organic material.

The single-use systems segment is the fastest-growing segment over the forecast period. These single-use systems have one type of media, generally sand or crushed anthracite coal. The general purpose of these filters which are designed to suppress undesirable electrical disturbances. Single-use filtration systems are comprised of many fully disposable components, including entire pathways and filters.

The pre-filters & depth media segment is projected to grow at a notable pace. The filter used in a pharmaceutical manufacturing environment is expected to play a crucial role in removing particles and reducing the bioburden. The filter downstream of a membrane filtration system is cheaper equipment; the filter can remove the solids that could foul the membrane, and it works more efficiently. For more demanding filter applications, glass fiber type filters are used as high dirt holding capacity filters, and PTFE fiber filters are used as high chemical resistance filters.

The cartridges & capsules segment is expected to witness steady growth during the forecast period due to the expansion of use in the sterile filtration and sterilisation of process fluids. They can be used in pharmaceutical manufacturing for high throughput, easy installation, and reliable contamination control. Used for the increasing production of biologics, vaccines, and injectable drugs.

Application Insights

The final product processing segment dominated the pharmaceutical filtration market in 2025. Final product processing in filtration in chemical processing is the most critical process, removing particles and clarifying the product are important and the quality and final product depend on the efficiency and cost-effectiveness of the final filtration process. The final filtration process can remove pharmaceutical residue, nitrites, nitrates, pesticides, hormones, and any heavy metals from the water.

The cell separation segment is projected to hit significant growth from 2025 to 2034. The most popular form of centrifugation used for cell separation is density gradient centrifugation. Density gradient centrifugation separates cell populations based on their respective densities with the help of a gradient medium. The most popular form of centrifugation used for cell separation is density gradient centrifugation.

The raw material filtration segment is projected to grow at a notable pace, with the importance of raw material filtration being to decontaminate them before their use in the manufacture of medicines. Applies media buffer filtration, pre-filtering, and bioburden testing to minimize contamination hazards. The quality of the raw material filter has to improve the effectiveness of manufacturing and uniformity of products. With biologics manufacturing on the rise, the need of the hour is advanced filtration technologies.

The water purification segment is expected to witness steady growth during the forecast period, driven by growing demand for high-purity water in the pharmaceutical industry. Purified water is an essential component in drug production, the cleaning of equipment, and laboratory applications. Increasing standards around water quality are driving investment in new and sophisticated filtration technology by the pharmaceutical industry.

Technique Insights

The microfiltration segment captured the biggest revenue share in the pharmaceutical filtration market in 2025. Microfiltration uses a microporous film to eliminate contaminations, foreign substances, protozoa, microbes, bacteria, viruses, micron-sized particles, and so on from a suspension/liquids/dissolvable. The microfiltration process is likewise a low-pressure driven layer process whose film pores are in the scope of 0.1-10 µm.

The ultrafiltration segment is expected to witness significant growth over the forecast period. Ultrafiltration systems contain extremely fine membrane filters which need to be properly cleaned. The cleaning process used depends on whether the ultrafiltration system is being used to remove organic or inorganic components or even both. Ultrafiltration is a type of filtration used in many industries like pharmaceutical and chemical manufacturing, wastewater treatment, and food and beverage processing to recycle flow or add value to later products.

The crossflow filtration segment is projected to grow at a notable pace due to its ability to separate impurities continuously with minimal membrane fouling. Components are used for protein purification, vaccine production, and processing in the biopharmaceutics industry in general. The improved product recovery, enhanced process efficiency, and reduced operation costs are hallmarks of this technique. The surge in biologic production is quickening the use of crossflow filtration.

The nanofiltration segment is expected to witness steady growth during the forecast period as nanofiltration can effectively remove viruses, endotoxins, and dissolved contaminants. It is increasingly beginning to be employed for purification of materials, such as water, or for active ingredients in pharmaceutical production. The nanofiltration selection enables you to successfully filter without losing valuable molecules and achieve a high degree of selectivity.

Scale of Operation Insights

The manufacturing scale segment registered a maximum market share in the pharmaceutical filtration market in 2025. The manufacturing scale segment includes the use of pharmaceutical filtration products for full-scale manufacturing of biologics and pharmaceutical products, such as cell therapies, gene therapies, vaccines, and protein-based therapeutics. In pharmaceutical filtration in manufacturing which removes contaminants from air and gas streams in many industrial processes. They can filter out particles like vapors, moisture, oils, and dust.

The research and development scale segment is predicted to hit notable growth over the forecast period. The increased investment and funding in research and development which help to increase the growth of the market. Research and development cover the initial search for a molecule to treat the disease through to having a product ready to market.

The pilot-scale segment is expected to experience considerable growth during the forecast period, due to the increase in pharmaceutical research and development processes. Filter systems can be installed on a trial basis to help the manufacturer optimize production in the actual manufacturing process before it's launched on commercial equipment. They can provide flexibility in the production of a clinical trial and small-scale production. As Biologics/Biosimilar products are being developed, the need for pilot-scale filters is growing.

Systems Insights

Which Single Use Segment Led the Pharmaceutical Filtration Market?

The single-use segment dominated the market in 2025, as it reduces the problems of contamination risks, cleaning, and validation needs. Single-use systems offer added flexibility in manufacture and reduce downtime. So, they're being used more and more to make medicines that rely on living organisms like biologics, vaccines, or personalized medicines. Demand for production using economies of scope and scale has positively influenced the growth of the segment.

The reusable segment is expected to witness notable growth, as the cost-effectiveness in large pharmaceutical manufacturing operations is a major driver of the segment. They are robust systems and are well suited for use in high-volume production systems. Advancements in technology have pushed cleaning and sterilization efforts further, making them cleaner, more efficient, and reliable. Big pharma spend is ongoing on reusable filtration systems for production cost optimisation.

Type Insights

Which Factors Contributed to the Sterile Filtration Segment Growth in the Pharmaceutical Filtration Market?

The sterile filtration segment dominated the market in 2025 due to requirements for a controlled area that is free from microorganisms in the pharmaceutical sector, as well as regulatory considerations. Sterile Filtration is used throughout the pharmaceutical industry to produce injectable drugs, vaccines, biological products, and eye care products. It basically helps in the removal of microorganisms and at the same time does not affect the qualities of the products.

The non-sterile Filtration segment is expected to witness notable growth with the demand for filtration beginning to increase in many intermediate manufacturing processes and raw material preparation. Particulate removal is a crucial process before the final product's sterilization. The scale of pharma product production has gone up, and the application of non-sterile filtration is gaining momentum.

Regional Insights

U.S. Pharmaceutical Filtration Market Size and Growth 2026 to 2035

The U.S. pharmaceutical filtration market size is estimated at USD 3.92 billion in 2025 and is predicted to be worth around USD 6.15 billion by 2035, at a CAGR of 4.61% from 2026 to 2035.

North America dominates the pharmaceutical filtration market with a revenue share of 41% in 2025. The pharmaceutical industry in North America operates under strict regulatory standards set by agencies such as the U.S. Food and Drug Administration (FDA) and Health Canada. These regulatory bodies require pharmaceutical companies to adhere to high-quality standards in the production of drugs and therapeutic products. Filtration is a critical process in ensuring the purity and safety of pharmaceutical products, making advanced filtration technologies essential for compliance.

North America has a sizable biopharmaceutical sector that focuses on the production of biologics, including vaccines, antibodies, and other complex therapeutic proteins. The manufacturing processes for biopharmaceuticals often involve intricate filtration steps, driving the demand for specialized filtration technologies.

The presence of advanced pharmaceutical industries, supportive governmental regulations, and advanced healthcare facilities help the growth of the market in the North American region. Increasing investment in research and development activities and better healthcare expenditure, which help the growth of the market.

• In August 2024, new specialized bioanalytical testing services in North America were introduced by SGS. This service can be used for both biopharmaceutical and pharmaceutical applications.

U.S. Pharmaceutical Filtration Market Trends

The U.S. is growing biopharmaceutical sector, there is an increasing adoption of single-use technologies and advanced membrane filters to ensure sterility and reduce contamination risks. Stringent regulatory requirements from the FDA also compel manufacturers to use robust filtration systems for safety and quality.
The Asia Pacific region has a booming biopharmaceutical sector and increased healthcare spending. This demand is amplified by growing outsourcing to regional contract manufacturing and development organizations (CDMOs) and robust government initiatives supporting the pharmaceutical industry in countries like India and China.

Asia Pacific is Undergoing the Fastest Growth in the Pharmaceutical Filtration Market

Asia Pacific is expected to grow at the fastest rate in the market, due to an increase in investment in biopharmaceutical production and in pharmaceutical research and development. The country is increasing indigenous knowledge of the human manufacture of biologics, vaccines, and specialty medicines. The use of sophisticated filtration systems is driving improvements in manufacturing efficiencies and regulatory standards. A life science innovation policy is taking shape at the national level and is the global leader in decreasing barriers for medicine manufacturing.

China Pharmaceutical Filtration Trends

China's pharmaceutical filtration market is anticipated to grow significantly due to the rapid development in pharmaceutical manufacturing industries, with its increased production of biologics. The country is undertaking significant investments to modernize manufacturing facilities and possess the latest manufacturing technologies. As exports of pharmaceuticals continue to increase, manufacturers are moving towards the use of high-quality filter systems in full compliance with international standards. The government is actively supporting domestic biopharmaceutical innovation, which prompts the need for advanced filtration.

How is Europe Rising in the Pharmaceutical Filtration Market?

Europe's market is a robust biopharmaceutical industry and a strict regulatory environment, which necessitates high-quality filtration. Key growth drivers include significant R&D investments, the widespread adoption of single-use technologies for efficiency, and strong government support for healthcare initiatives.

Germany Pharmaceutical Filtration Market Trends

The German pharmaceutical filtration industry is growing as the pharmaceutical and biotech industries expand. Membrane filters are the largest product segment for sterile processing and biologics. Single-use filtration systems are increasingly adopted to reduce contamination and improve flexibility. Strict EU and German regulations drive demand for high-quality and efficient filtration solutions.

United Kingdom Pharmaceutical Filtration Trends

The U.K. has strong biopharmaceutical and vaccine sectors, alongside the widespread adoption of single-use technologies for enhanced efficiency and reduced contamination risk. Stringent regulatory demands from the MHRA necessitate the use of reliable, high-performance filtration solutions.

Sterile Filtration in Biopharmaceuticals in Latin America

Latin America shows a notable growth during the forecast period. It is driven by increased investment in healthcare infrastructure along with the adoption of single-use technologies. Companies in Brazil use 0.22 µm filtration to prevent microbial contamination and even remove impurities, ensuring product sterility.

Meanwhile, the move toward single-use filters simplifies manufacturing, decreases cleaning validation costs, and minimizes cross-contamination risks, mainly in expanding markets like Brazil.

Brazil Pharmaceutical Filtration Market Trends

The Brazilian pharmaceutical filtration industry is growing as pharmaceutical and biopharmaceutical production expands. Membrane filters are the most commonly used products for sterile processing and particulate removal. Single-use and advanced filtration technologies are gaining popularity to reduce contamination and improve efficiency. Strict regulations and investments in modern filtration systems are driving further demand.

Membrane Filtration Technologies in Pharma in MEA

MEA shows a rapid growth during the forecast period. This is due to the urgent demand for sterile drug production, the rising need for biologics, and even regional shifts toward localizing pharmaceutical manufacturing. Membrane filters are vital for removing bacteria and viruses from drug products, guaranteeing compliance with strict international GMP and also local quality standards. The demand for rapid production of vaccines along with medications accelerated the demand for high-throughput, efficient sterilization solutions.

The UAE Pharmaceutical Filtration Market Trends

The UAE pharmaceutical filtration industry is growing steadily as the country expands its pharmaceutical manufacturing base to meet rising demand for high quality drugs, biologics, and vaccines. Membrane filters and advanced sterile filtration systems are leading product segments, driven by stringent regulatory compliance and the need to ensure purity and safety in drug production.

Pharmaceutical Filtration Market Value Chain Analysis

• Raw Material Sourcing/Component Suppliers
  This stage involves the procurement of essential materials such as polymers for membranes, resins, additives, and other components used to manufacture filtration products. The quality and availability of these materials are critical to the performance and consistency of the final filtration solution.
  Key Players: Sartorius AG, Merck KGaA, and Danaher Corporation (Pall Corporation).
• Manufacturing and Assembly
  In this stage, raw materials are converted into finished filtration products like membrane filters, depth filters, single-use systems, cartridges, and capsules. Manufacturers invest heavily in R&D to develop innovative technologies, such as nanofiber membranes and automated systems, to meet the industry's stringent purity and efficiency requirements.
  Key Players: Danaher Corporation (Pall Corporation), Sartorius AG, Merck KGaA, 3M Company, Thermo Fisher Scientific Inc., Parker Hannifin Corporation, and Eaton Corporation Plc.
• Distribution and Logistics
  This stage focuses on efficiently delivering the manufactured filtration products from the production facilities to the end-users. This involves managing complex supply chains, often globally, to ensure timely delivery and compliance with specific handling and storage conditions.
  Key Players: McKesson and Cardinal Health

Competitive Landscape

The pharmaceutical filtration market is semi-consolidated, with several multinational filtration specialists controlling a significant share of the high-value sterile processing systems market. On the other hand, regional vendors are active in providing membranes, cartridges, and single-use assemblies. Prominent companies such as Cytiva and Pall leverage their strategic advantages with biologics portfolios, strong regulatory know-how, and global manufacturing capabilities. Market competition is now being fueled through acquisitions, expanded production capabilities, and collaborations related to cell and gene therapy development.

Next-generation technology enabling AI-powered process monitoring tools, high-throughput membrane solutions, and cutting-edge single-use filtration platforms is becoming a key differentiator within the market. However, very high validation costs, strict GMP compliance requirements, intellectual property challenges, and long qualification processes all represent significant entry barriers for new entrants. Nevertheless, the demand coming from biologics and mRNA manufacturing will be a catalyst for more competitive investment in the near future.

• In July 2025, Novasign partnered with Repligen Corporation to successfully implement machine learning and digital modelling in tangential flow filtration systems. The collaboration will enable the optimisation of processes with the help of AI and will help to put bioprocess digitalization into practice rapidly. (Source: https://investors.repligen.com)
• In July 2025, Thermo Fisher Scientific united with Sanofi to acquire Sanofi's sterile manufacturing facility in New Jersey, furthering its strategic alliance with the pharmaceutical company. The partnership collaborates on promoting U.S. capabilities in sterile drug manufacturing and the supply of critical medicines. (Source: https://ir.thermofisher.com)

Pharmaceutical Filtration Market Companies

• Graver Technologies, LLC:
  Focuses on highly specialized filtration, purification, and separation products, providing solutions for pharmaceutical water systems and process streams that meet stringent regulatory needs. They offer cartridge filters and other media designed for specific applications in sterile filtration and clarification.
• Meissner Filtration Products, Inc.:
  Specializes in microfiltration and single-use systems, providing a broad portfolio of filters and fluid management solutions for critical pharmaceutical and bioprocessing applications. They contribute through innovation in depth filtration, membrane technologies, and customized product designs to meet specific client needs.
  Merck & Co., Inc. (Note: The filtration market segment is primarily part of Merck KGaA/MilliporeSigma):
  A major contributor through its Life Science business (MilliporeSigma), providing a vast array of filtration products crucial for R&D and production of biologics and pharmaceuticals. Their products are essential for cell culture media preparation, protein purification, and sterile filtration processes globally.
• Parker-Hannifin Corporation:
  Through its Finite Air and other divisions, it provides high-purity process and sterile air filtration solutions essential for sterile manufacturing environments. Their technology ensures air quality and contamination control, vital for maintaining GMP compliance in pharmaceutical production areas.
• Sartorius Stedim Biotech S.A.:
  A leading international partner for the biopharmaceutical industry, offering integrated solutions for all steps of bioprocesses, including media preparation, cell culture, and downstream processing. Their filtration products are a core component of their extensive single-use technology portfolio, minimizing cross-contamination risks.
• 3M Company:
  Provides various advanced filtration solutions for both pharmaceutical water treatment and process stream clarification. Their depth filtration and microfiltration technologies are used across different stages of drug manufacturing to ensure product quality and safety.
• Amazon Filters Ltd.:
  A privately-owned European manufacturer offering a wide range of process filtration equipment for the water, chemical, and pharmaceutical sectors. They contribute with customized filter housings, depth filters, and pleated cartridges designed to meet specific regulatory requirements and production needs.
• Danaher Corporation (Pall Corporation):
  A dominant player offering a comprehensive range of separation, filtration, and purification technologies essential for bioprocessing and general pharmaceutical manufacturing. They are major innovators in single-use systems and advanced membrane filters crucial for large-scale biologics production.
• Eaton Corporation Plc:
  Provides industrial filtration systems, including depth filtration and automatic self-cleaning filters, often used in upstream processing and water treatment applications within pharmaceutical facilities. Their products focus on improving efficiency and reducing waste in bulk manufacturing processes.
• General Electric Company (GE Healthcare - now Cytiva, a Danaher company):
  (Now operating as Cytiva following acquisition by Danaher) Offers extensive bioprocessing solutions, including a wide range of filtration systems used in chromatography, cell harvesting, and final product polishing. Their technologies are integral to the efficient production of complex biologics and cell therapies.

Recent Developments

• In July 2025, Asahi Kasei Corporation announced a new plant to spin its Planova virus removal filters for bioprocessing worldwide. The project was funded under the framework of the biopharmaceutical supply strengthening project of the Ministry of Economy, Trade and Industry, Japan. (Source: https://www.asahi-kasei.com)
• In July 2025, Repligen Corporation teamed up with Novasign to incorporate machine learning and advanced modeling workflows with its tangential flow filtration systems. The goal of the partnership is to achieve the most efficient filtration along with more efficient bioprocessing. (Source: https://investors.repligen.com)
• In April 2025, Parker Bioscience Filtration launches a new technology specifically created to support integration of Pre-Use Post-Sterilization Integrity Testing for biopharmaceutical filtration applications. The solution can help manufacturers improve their products' safety, process reliability, and regulatory compliance. (Source: https://www.bioprocessonline.com)
• In October 2024, Planova FG1, a virus removal filter featuring higher flux for the manufacture of biotherapeutics was launched by Asahi Kasei Medical.
• In December 2024, an enhanced high-temperature resistant membrane product aimed at vent applications across the global pharmaceutical and biotechnology markets was launched by the UK's Amazon Filters.

Segments Covered in the Report

By Product

• Membrane Filters
• MCE membrane filters
• Coated cellulose acetate membrane filters
• PTFE membrane filters
• Nylon membrane filters
• PVDF membrane filters
• Other membrane filters
• Pre-filters & Depth Media
• Glass fiber filters
• PTFE fiber filters
• Single-use Systems
• Cartridges & Capsules
• Filter Holders
• Filtration Accessories
• Filtration Assemblies
• Others

By Technique

• Microfiltration
• Ultrafiltration
• Crossflow filtration
• Nanofiltration
• Others

By Application

• Final Product Processing
• Active pharmaceutical ingredient filtration
• Sterile filtration
• Protein purification
• Vaccines and antibody processing
• Formulation and filling solutions
• Viral clearance
• Raw Material Filtration
• Media buffer
• Pre-filtration
• Bioburden testing
• Cell Separation
• Water Purification
• Air Purification

By Scale of Operation

• Manufacturing scale
• Pilot-scale
• Research & development scale

By Systems

• Single Use
• Reusable

By Type

• Sterile Filtration
• Non-Sterile Filtration

By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa